Carlos Becerra Selected Research

Carlos Becerra Research Topics

Disease

13	Neoplasms (Cancer) 01/2021 - 03/2003
6	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2005
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 03/2003
3	Nausea 11/2016 - 01/2016
3	Fatigue 11/2016 - 01/2016
2	Vomiting 11/2016 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 02/2011
2	Colonic Neoplasms (Colon Cancer) 07/2010 - 04/2003
2	Polyps 04/2003 - 03/2003
1	Bone Diseases (Bone Disease) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019
1	Neutropenia 10/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2018
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 10/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2018
1	Hematologic Neoplasms (Hematological Malignancy) 10/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2016
1	Diarrhea 11/2016
1	Stomach Neoplasms (Stomach Cancer) 01/2016
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2015
1	Fetal Death 04/2005
1	Fetofetal Transfusion (Twin Transfusion Syndrome) 04/2005
1	Congenital Hypothyroidism (Cretinism) 03/2003

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 11/2016 - 09/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2020 - 11/2019
2	Gemcitabine FDA Link 01/2016 - 02/2011
1	Letrozole (Femara)FDA LinkGeneric 01/2021
1	NucleotidesIBA 01/2021
1	Aromatase InhibitorsIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	abemaciclibIBA 01/2021
1	exemestane (Aromasin)FDA Link 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Tamoxifen FDA LinkGeneric 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	trametinibIBA 01/2020
1	GSK2141795IBA 01/2020
1	taxaneIBA 11/2019
1	Docetaxel (Taxotere)FDA Link 11/2019
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 11/2019
1	trifluridine tipiracil drug combinationIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2018
1	Azacitidine (5 Azacytidine)FDA Link 10/2018
1	cc-486IBA 10/2018
1	dactolisibIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 11/2016
1	Tyrosine Kinase InhibitorsIBA 11/2016
1	Capsules (Microcapsules)IBA 11/2016
1	TabletsIBA 11/2016
1	ASG-5MEIBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	LY2603618IBA 01/2016
1	Immunoconjugates (Immunoconjugate)IBA 01/2016
1	Conjugate VaccinesIBA 01/2015
1	Immunoglobulin G (IgG)IBA 01/2015
1	enzastaurinIBA 02/2011
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2005
1	Ampicillin (Omnipen)FDA LinkGeneric 09/2005
1	Tumor Biomarkers (Tumor Markers)IBA 09/2005
1	Proteins (Proteins, Gene)FDA Link 04/2003
1	AgarIBA 04/2003
1	Small Interfering RNA (siRNA)IBA 04/2003
1	beta CateninIBA 04/2003
1	Complementary DNA (cDNA)IBA 03/2003
1	SurvivinIBA 03/2003
1	Sodium Pertechnetate Tc 99m (Pertechnetate)FDA Link 03/2003

Therapy/Procedure

2	Therapeutics 01/2021 - 02/2011
2	Adjuvant Chemotherapy 01/2018 - 07/2010
1	Drug Therapy (Chemotherapy) 01/2021
1	Lasers (Laser) 04/2005
1	Light Coagulation 04/2005
1	Laser Therapy (Surgery, Laser) 04/2005